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Abstract The clostridial neurotoxin, tetanus toxin, is a Zn2+-dependent protease which inhibits neurotransmitter exocytosis by selective cleavage 
of the synaptic vesicle protein, synaptobrevin. Synaptobrevin is thought to serve as a receptor for two neuronal plasma membrane proteins, syntaxin 
and SNAP-25, which in the presence of non-hydrolyzable ATP analogs form a 20 S fusion complex with the soluble fusion proteins NSF and s-SNAP. 
Here we show that synaptobrevin, when in this 20 S complex, or its 7 S precursor, is protected against proteolysis by the enzymatically active tetanus 
toxin light chain. Our data define distinct pools of synaptobrevin, which provide markers of different steps of vesicle/plasma embrane interaction. 
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1. Introduction 
Synaptic release of neurotransmitters is triggered by calcium 
and occurs via exocytotic fusion of synaptic vesicles with the 
presynaptic plasma membrane [1]. Recent studies indicate that 
an evolutionarily conserved set of protein interactions utilized 
at different stages of vesicle-based intracellular protein trans- 
port is also essential for synaptic vesicle/plasma membrane 
fusion [2]. In particular, the ubiquitous ATPase N-meth- 
ylmaleimide-sensitive _fusion protein (NSF) and the soluble 
NSF attachment proteins (SNAPs) have been implicated in 
transmitter secretion because of their ability to associate with 
the vesicle membrane protein, synaptobrevin (or VAMP), and 
the plasma membrane proteins, syntaxin and SNAP-25 (for 
synaptosomal ssociated protein of 25 kDa) [3]. Since these 
latter proteins bind to 0t-SNAP, they were named SNAREs 
S(~ap Receptors) [3]. 
Upon solubilization the SNAREs form a stable complex 
which sediments at 7 S and is postulated to mediate selective 
docking of synaptic vesicles at the plasma membrane [4,5]. A 
sequence of post-docking intermediates involving the SNAREs 
has also been postulated from in vitro observations. One of the 
7 S complexes also contains synaptotagmin, another vesicle 
protein proposed to constitute the Ca 2+ receptor that triggers 
membrane fusion [6,7]. SNARE associated synaptotagmin s 
displaced from the 7 S complex upon binding of o-SNAP, 
which in turn allows NSF recruitment into the SNARE com- 
plex. In the presence of a non-hydrolyzable ATP analog the 
interactions between all aforementioned proteins are main- 
tained, and the resulting complex can be identified as an entity 
that migrates at 20 S. In contrast, ATP hydrolysis by NSF 
disrupts the 20 S complex, a process that has been postulated 
to drive vesicle/plasma membrane fusion [3,4,8]. 
The importance of the protein interactions outlined above is 
strengthened byindependent evidence showing that the synap- 
tosomal SNAREs are the targets of clostridial neurotoxins, the 
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most potent inhibitors of neurotransmitter r lease known [9]. 
These toxins are composed of a heavy chain responsible for 
target cell specificity, and a light chain which acts as a Zn 2÷- 
dependent endoprotease. Synaptobrevin s specifically cleaved 
by tetanus toxin and botulinum toxin B, D and F light chains 
[10-12], whereas syntaxin and SNAP-25 are substrates for 
other botulinum toxin serotypes [13,14]. These toxin proteases 
have been shown to utilize unique sites in the polypeptide se- 
quence [9]. In squid, where the cleavage site of synaptobrevin 
is conserved, tetanus toxin injection into the presynaptic termi- 
nal of the giant synapse leads to disruption of a post-docking 
step in synaptic vesicle fusion [15]. Thus, the role of the 
SNAREs in the release mechanism ay extend beyond simple 
membrane recognition. One way to address this issue is to 
investigate the toxin sensitivity of the SNAREs within distinct 
fusion complex intermediates produced in vitro. In this study 
we show that synaptobrevin s protected from tetanus toxin 
cleavage in both the 7 S and 20 S complex, a result hat extends 
the idea [15] that this SNARE may directly function at multiple 
points of the vesicle fusion mechanism. 
2. Materials and methods 
2.1. Materials 
The light chain of tetanus toxin [16] was a gift of Prof, E. Habermann. 
pQE9 vectors containing the full length coding sequence of NSF [3] and 
or-SNAP [17], kindly provided by Drs. J. Rothman and T. S611ner, were 
used to produce recombinant His6-NSF-myc and His6-ct-SNAP as de- 
scribed [17]. His6-NSF-myc and His6-~t-SNAP protein concentrations 
were estimated by Coomassie blue staining of SDS-PAGE samples and 
compared against known quantities of the marker proteins, bovine 
serum albumin and glyceraldehyde-6-phosphate dehydrogenase. Prior 
to use, the His6-NSF-myc was concentrated over Centricon 30 filters 
(Amicon). 
2.2. Membrane xtracts 
The solubilization of salt-washed crude rat brain membranes with 
Triton-X-100 was performed as described [3]. Protein content was esti- 
mated by a modified Lowry procedure [18]. 
2.3. 20 S Fusion complex assembly and disassembly 
The distinct intermediates of the SNARE complex were formed from 
brain membrane xtracts essentially as described [3,4]. The Triton X- 
100 extracts were used directly or after dilution into reaction buffer (20 
mM HEPES-KOH, pH 7.0, 100 mM KC1, 1 mM dithiothreitol, 0.5% 
(w/v) Triton X-100); for immunoprecipitation experiments the reaction 
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buffer also contained 1% (w/v) polyethyleneglycol 4000 and 1% (w/v) 
glycerol. In all experiments basic incubations were supplemented with 
either no additions (7 S); His6-ct-SNAP alone (+a-SNAP); Hisr-ot- 
SNAP and His6-NSF-myc fusion proteins under either ATP non-hy- 
drolizing (20 S) or hydrolizing (Dis20S) conditions. The reactions were 
incubated for 30 min at 4°C and cleared by centrifugation. Then tetanus 
toxin light chain was added, and incubations continued at 37°C for 40 
min. As extended periods at this temperature are known to compromise 
NSF function in vitro [19], two controls without oxin were routinely 
performed at 4°C and 37°C, although no differences were apparent 
between these two controls (data not shown). Tetanus toxin cleavage 
of different pools of synaptobrevin in these in vitro incubations was 
analyzed by either glycerol gradient centrifugation r immunoprecipi- 
tation using methods detailed elsewhere [4]. Immunoprecipitations were 
made with the syntaxin specific mAb 10H5 [20] covalently coupled to 
fast-flow protein A-Sepharose b ads (100/2g/10/21 beads). 0.1 M glycine 
(pH 2.7) was used to elute the proteins bound to the beads. 
2.4. Gel-electrophoresis andWestern blotting 
Protein samples from glycerol gradients or immunoprecipitations 
were concentrated bytrichloroacetic a id precipitation [21] and sub- 
jected to SDS-PAGE on 15% gels [22] before transfer to nitrocellulose. 
The blots were cut into four horizontal strips corresponding to the 
apparent molecular weight ranges of 14-20, 21-30, 30~5, and >45 
kDa, and immunodecorated with antibodies raised against synapto- 
brevin [23], SNAP-25 (Affiniti Research Products Ltd.), syntaxin [20] 
and synaptotagmin (mAb 1D 12; see [20]), respectively. Immunoreactiv- 
ity was detected using horseradish peroxidase-coupled s condary anti- 
body in combination with the ECL detection system (Amersham). De- 
tection of NSF and or-SNAP immunoreactivities [4] was performed by 
reprobing the 30-45 kDa and > 45 kDa strips after inactivating the 
original secondary antibodies with 0.05% (w/v) sodium azide. 
3. R ~  
3.1. Tetanus toxin cleavage of  synaptobrevin membrane 
extracts 
Incubation of Triton X-100 extracts prepared from rat brain 
membranes with tetanus toxin light chain indicated that effi- 
cient and specific cleavage of synaptobrevin described for more 
intact preparations [10] was retained in the presence of deter- 
gent, although both isoforms of synaptobrevin were cleaved 
(Fig. 1). A minor proportion of the synaptobrevin present was, 
however, resistant to toxin cleavage ven after prolonged incu- 
bation (> 2 h; see Fig. 1, and results not shown). This prompted 
us to investigate whether an association of synaptobrevin with 
the SNAREs SNAP-25 and syntaxin could account for this 
protection. Upon the addition of recombinant ~-SNAP alone 
or together with Hisr-NSF-myc and ATP-7-S, synaptobrevin 
that appeared insensitive to tetanus toxin cleavage was still 
observed. In contrast, when the ~-SNAP and NSF recombinant 
proteins were added in the presence of ATP, synaptobrevin was 
completely digested (Fig. 1). Since these conditions favour 20 
S complex disassembly [4], only uncomplexed synaptobrevin 
appeared to be digested by the toxin. 
3.2. Investigation of synaptobrevin cleavage by gradient 
sedimentation 
To extend the observations made with crude membrane ex- 
tracts, the latter were incubated under conditions promoting 
distinct stages of complex formation and then separated by 
glycerol gradient centrifugation [3,4]. This analysis revealed the 
expected istribution of SNAREs. With no additions to the 
crude extract, syntaxin, SNAP-25 and synaptobrevin co-sedi- 
mented in a peak of about 7 S (Fig. 2A, 7S). Under these 
conditions, ynaptobrevin in addition exhibited a peak of im- 
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Fig. 1. Tetanus toxin cleavage of detergent-solubilized synaptobrevin. 
Salt-washed rat brain membranes (40/2g of protein) were incubated for 
30 min at 4°C in a final volume of 15/21 either alone (7S), in the presence 
of 3/2g of His6-~t-SNAP (+or-SNAP), or in the presence of 3/2g of 
His6-NSF-myc and 1.25/2g Hisr-ct-SNAP in buffer supplemented with 
either 2 mM MgC12 and 0.5 mM ATP-)'-S (20S) or ATP (Dis20S). 
Incubation was then continued at 37°C for 40 min in the absence (-) 
or presence (+) of 600 ng of tetanus toxin light chain. 
munoreactivity in the lightest fractions, which is indicative of 
a pool of solubilized synaptobrevin that is distinct from that 
co-distributing with syntaxin and SNAP-25.20 S complex con- 
ditions caused a re-distribution i to denser fractions of all 
SNARE proteins, with a peak at > 15 S (Fig. 2A, 20S). The 
positions of His6-~-SNAP and His6-NSF-myc immunoreactivi- 
ties in these gradients were consistent with the formation of a 
multimeric c-SNAP/NSF/SNARE complex (data not shown). 
Under the conditions used, approximately 50% of the synap- 
tobrevin immunoreactivity was found in these denser fractions, 
which confirms original observations of Srllner et al. [4]. Under 
complex disassembly conditions (Fig. 2A, Dis20S), there was 
a small but discernable shift in the distribution of SNAREs to 
lighter fractions, this being most marked for synaptobrevin (see 
also [5]). In contrast, the distribution of synaptotagmin im- 
munoreactivity was unchanged by the incubation conditions; 
the small fraction of ~t-SNAP displaceable synaptotagmin that 
associates with the 7 S complex [4] could therefore not be 
adequately tracked by glycerol gradient centrifugation. 
The distinct pools of synaptobrevin fractionat'ed on the gyc- 
erol gradients were analyzed for their susceptibility ocleavage 
by tetanus toxin. For this purpose fractions enriched in either 
associated or uncomplexed synaptobrevin were divided and 
incubated with or without etanus toxin light chain (Fig. 2B). 
In all cases the fractions enriched in 7 S or 20 S complex showed 
an almost complete protection of synaptobrevin against oxin 
cleavage. In contrast, light fractions containing non-associated 
synaptobrevin showed very marked egradation. This strength- 
ens the view that complexed synaptobrevin is protected against 
tetanus toxin action. 
3.3. Immunoprecipitation a alysis 
To better define the pool of synaptobrevin that resists tetanus 
toxin cleavage, we immunoprecipitated distinct fusion complex 
intermediates [4]. In a first set of experiments, extracts were 
incubated to produce different fusion complex intermediates, 
subjected to tetanus toxin light chain treatment, and im- 
munoprecipitated on syntaxin immunobeads before analysis 
of the resulting pellets and supernatants. Under 7 S conditions, 
all characterized components of this 'precursor' complex were 
efficiently precipitated (Fig. 3, 7S). The specificity of our 
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Fig. 2. Effect of tetanus toxin light chain on fusion complexes enriched 
by glycerol gradient centrifugation. Salt-washed rat brain membranes 
(200 gg of protein) were incubated at 4°C for 30 min in reaction buffer 
without addition (7S), in the presence of 15 pg of His6-~-SNAP without 
(+~z-SNAP), or with 15 ltg of His6-NSF-Myc supplemented with 0.5 
mM ATP and either 2 mM EDTA (20S), or 2 mM MgCI 2 (Dis20S). The 
samples were then subjected to centrifugation ver glycerol gradients 
made up in buffers appropriate for the complex intermediate investi- 
gated. Aliquots (300 gl) of gradient fractions were (A) precipitated and 
analyzed by SDS-PAGE and immunoblotting, and (B) in parallel incu- 
bated at 37°C for 40 min under agitation i  the absence (-) or presence 
(+) of 1.5 gg of tetanus toxin light chain prior to protein precipitation, 
SDS-PAGE and immuncblotting. 
immunoprecipitation conditions was apparent from parallel 
incubations made with anti-synaptophysin (SY38; see [24]) im- 
munobeads, which failed to co-isolate synaptophysin with any 
of the SNAREs (data not shown). The amounts of synapto- 
brevin precipitated from either untreated or toxin treated 7 S 
extracts were very similar. However, efficient cleavage of syn- 
aptobrevin is indicated by a marked decrease of synaptobrevin 
immunoreactivity n the supernatants of the extracts incubated 
with tetanus toxin light chain; a small fraction of uncleaved 
synaptobrevin  these supernatants probably reflects incom- 
plete immunoprecipitation of the solubilized 7 S complex. Very 
similar results were obtained upon addition of cz-SNAP and 
under 20 S conditions (Fig. 3, +ct-SNAP and 20S). Again, the 
synaptobrevin immunoprecipitated by the syntaxin antibodies 
was resistant to cleavage by tetanus toxin light chain, although 
the amount of associated synaptotagmin decreased as or-SNAP 
bound to the complex. When extracts are supplemented with 
cz-SNAP, NSF and ATP, the complex immunoprecipitated by 
syntaxin antibodies is disrupted [3,4]. This was demonstrated 
here by a decrease in immunoprecipitated synaptobrevin and 
SNAP-25 (Fig. 3, Dis20S). Under these conditions, synapto- 
brevin previously associated with the 7 S complex became sensi- 
tive to cleavage. It is interesting that immunoprecipitates from 
the tetanus toxin light chain treated extracts howed a complete 
absence of synaptobrevin mmunoreactivity, although in un- 
treated extracts ome remained. This might indicate that the 
toxin also acts on partially disassembled fusion complexes. Ad- 
ditional immunoblots with an antibody specific for the amino 
acid sequence 36-57 of synaptobrevin [5] showed that the 
cleaved N-terminal fragment of synaptobrevin was released 
into the supernatant (data not shown). 
To ensure that the above observations were not due to a 
preferential re-equilibration of uncleaved synaptobrevin to 
the 7 S complex, this intermediate was separated from the 
solubilized synaptobrevin and used as a precursor for further 
manipulations. This was achieved by binding the 7 S complex 
to syntaxin immunobeads and incubating this with components 
as described for the crude membrane xtract. The resulting 
immunoisolates were then incubated with or without tetanus 
toxin light chain. The comparatively poor displacement of syn- 
aptotagmin and the weak release of synaptobrevin to the 
supernatant seen under Dis20S conditions uggest inefficient 
complex disassembly on the immunobeads. Despite this limita- 
tion, the bead approach clearly revealed that the resistance of 
synaptobrevin to tetanus toxin cleavage isdue to its interaction 
with the other SNAREs and, secondly, that this resistance 
appears unaffected by the protein-protein i teractions that 
characterize the formation of a 20 S complex from the 7 S 
intermediate (Fig. 4). In contrast, conditions that induced dis- 
ruption of the 20 S complex caused release of associated synap- 
tobrevin which then was completely degraded by the toxin's 
light chain. Control experiments with the protease ficin showed 
that synaptobrevin i  the bead-bound 20 S complex is in prin- 
ciple accessible to proteases (data not shown). 
4. D iscuss ion  
The discovery that the light chain of tetanus toxin is a Zn 2÷- 
dependent protease which exhibits a marked substrate specific- 
ity for the synaptic vesicle protein synaptobrevin, afforded an 
elegant explanation of this protein's potent neurotoxicity [10]. 
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Fig. 3. Immunoprecapitation of fusion complexes from extracts treated with tetanus toxin light chain. Salt-washed rat brain membranes (40/.tg of 
protein) were incubated inimmunoprecipitation buffer with additions as shown in Fig. 1, before further incubation at37°C for 40 min, in the absence 
(-) or presence (+) of 600 pg of tetanus toxin light chain. The samples were then immunoprecipitated to give pellets (P) and supernatants (S)for 
further analysis. 
It also provided strong evidence that synaptobrevin plays an 
essential role in the neurotransmitter r lease process. Biochem- 
ical experiments have defined synaptobrevin as a component 
of a synaptosomal protein complex that is assumed to mediate 
vesicle docking and fusion [3-5]. In particular synaptobrevin's 
in vitro association with the presynaptic plasma membrane 
SNAREs, SNAP-25 and syntaxin, has been postulated to con- 
stitute the cellular correlate of docked synaptic vesicles [5]. This 
synaptobrevin containing 7 S complex that recruits cz-SNAP 
and NSF provides a plausible model of how vesicle fusion at 
specialized cellular locations, like the nerve terminal, can be 
catalyzed by an ubiquitous et of cytosolic proteins. Our data 
showing that synaptobrevin complexed with its cognate 
SNAREs is insensitive to tetanus toxin cleavage indicates that 
upon docking synaptobrevin becomes resistant to tetanus 
toxin. The finding that only a small fraction of solubilized 
synaptobrevin is resistant to cleavage by tetanus toxin is consis- 
tent with morphological data showing that only a small fraction 
of the total vesicle pool is docked [25]. If the tetanus toxin- 
insensitive pool of synaptobrevin s indeed representative of
docked vesicles, the toxin can provide a sensitive tool to meas- 
ure the biogenesis of the docked state. Notably, although the 
pool of docked vesicles is small, it represents he physiologically 
most active population, being the pool used in the triggered 
release of neurotransmitter [25]. Therefore, the slow action of 
toxin seen when it is directly introduced into nerve terminals 
[10,15] may relate, partly, to the inaccessibility of toxin to the 
SNARE complexed synaptobrevin. 
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Fig. 4. Tetanus toxin cleavage of immobilized fusion complexes. Salt-washed rat brain membranes (40 gg of protein) were incubated for 30 min at 
4°C in immunoprecipitation buffer in a final volume of 100 gl and immunoprecipitated with an equal volume of antisyntaxin-coupled rotein A beads. 
After 5 washes in immunoprecipitation buffer, the beads were gently mixed for 60 min at 4°C in a final volume of 100 ,ul without addition (7S), in 
the presence of 7.5/tg of His6-c(-SNAP (+s-SNAP), or in the presence of 2 mM MgCI2, 3 gg of His6-~-SNAP and 7.5 gg His6-NSF-myc with 5 mM 
of either ATP-~,-S (20S) or ATP (Dis20S). After incubation for 40 min at 370C in the absence (-) or presence (+) of 900 ng of tetanus toxin light 
chain and 5 washes in immunoprecipitation buffer containing ATP and ATP-~,-S as required, the supernatants and subsequent washes were pooled 
(S) before analysis in parallel with proteins eluted from the washed immunoprecipitates (P). 
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The protection of synaptobrevin i  all intermediates of 20 S 
complex assembly is difficult o reconcile with it serving simply 
to ensure compartment-specific membrane recognition. As 
mentioned above, terminals exhibiting tetanus toxin perturbed 
neurotransmitter release show an increase in the number of 
docked vesicles [15]. Assuming that these morphologically de- 
fined organelles represent fusion competent vesicles, either for- 
mation of the 7 S complex is not the biochemical correlate of 
docking, or synaptobrevin has multiple functions in the release 
process. If the latter is true, the membrane anchored synapto- 
brevin fragment obtained upon cleavage may be sufficient o 
mediate vesicle docking, whereas post-docking functions of 
synaptobrevin may be destroyed by loss of the N-terminal 
cleavage fragment [10]. Possible post-docking functions of syn- 
aptobrevin may include the SNAP-25 mediated increase in the 
affinity of SNARE interactions [5], accomodation of SNAP 
and NSF mediated interactions, or a direct role of synapto- 
brevin in the membrane re-arrangements that underlie exocy- 
totic vesicle fusion [4]. 
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